Pricing Log in Create free account

Affimed N.V. (AFMDQ) vs HCW Biologics Inc. (HCWB)

Affimed N.V. and HCW Biologics Inc. are both Biotechnology companies. Affimed N.V. and HCW Biologics Inc. are of similar size ($2.8M and $2.8M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against −95.2%. HCW Biologics Inc. has the higher net margin (−329.4% vs −7,834.6%) and the higher return on invested capital (−36.2% vs −13,558.8%). Across the 15 metrics below, HCW Biologics Inc. leads on 8 and Affimed N.V. on 7.

Valuation

Metric AFMDQ HCWB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.25 9.71
P/B n/m 0.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.26 n/m 0.64
EV/Sales (19.16) 1.17 9.21
Earnings yield 0.00% (2,225.58%) (33.15%)
Free cash flow yield 0.00% (752.91%) (25.50%)

Profitability

Metric AFMDQ HCWB Biotechnology median
Gross margin 100.00% 95.91% 65.16%
Operating margin (7,858.63%) (114.02%) 0.00%
Net margin (7,834.59%) (329.38%) 0.00%
Free cash flow margin (8,603.91%) (180.57%) 0.00%
Return on equity (148.64%) (600.32%) (56.36%)
Return on assets (86.68%) (79.52%) (48.04%)
Return on invested capital (13,558.83%) (36.15%) 0.00%

Growth

Metric AFMDQ HCWB Biotechnology median
Revenue growth (TTM) (95.23%) 706.96% 6.02%
EPS growth (last fiscal year) (21.75%) 65.49% 30.26%
Revenue growth, 5-year CAGR (20.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ HCWB Biotechnology median
Debt to equity 0.47 0.88 0.00
Current ratio 1.93 0.06 4.72
Net debt to EBITDA 0.58 (0.40) 0.96

Dividend

Metric AFMDQ HCWB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AFMDQ HCWB Biotechnology median
Market cap 2.76m 2.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack